Vähä-Koskela M - Search Results

1

Replication competent Semliki Forest virus prolongs survival in experimental lung cancer.

Määttä AM, Mäkinen K, Ketola A, Liimatainen T, Yongabi FN, Vähä-Koskela M, Pirinen R, Rautsi O, Pellinen R, Hinkkanen A, Wahlfors J. Määttä AM, et al. Int J Cancer. 2008 Oct 1;123(7):1704-11. doi: 10.1002/ijc.23646. Int J Cancer. 2008. PMID: 18651570 Free article.

2

Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models.

Määttä AM, Liimatainen T, Wahlfors T, Wirth T, Vähä-Koskela M, Jansson L, Valonen P, Häkkinen K, Rautsi O, Pellinen R, Mäkinen K, Hakumäki J, Hinkkanen A, Wahlfors J. Määttä AM, et al. Int J Cancer. 2007 Aug 15;121(4):863-70. doi: 10.1002/ijc.22758. Int J Cancer. 2007. PMID: 17443493 Free article.

3

MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.

Martikainen M, Niittykoski M, von und zu Fraunberg M, Immonen A, Koponen S, van Geenen M, Vähä-Koskela M, Ylösmäki E, Jääskeläinen JE, Saksela K, Hinkkanen A. Martikainen M, et al. J Virol. 2015 Oct;89(20):10637-47. doi: 10.1128/JVI.01868-15. Epub 2015 Aug 12. J Virol. 2015. PMID: 26269187 Free PMC article.

4

Tumor Restrictions to Oncolytic Virus.

Vähä-Koskela M, Hinkkanen A. Vähä-Koskela M, et al. Biomedicines. 2014 Apr 17;2(2):163-194. doi: 10.3390/biomedicines2020163. Biomedicines. 2014. PMID: 28548066 Free PMC article. Review.

5

A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus.

Vähä-Koskela MJ, Tuittila MT, Nygårdas PT, Nyman JK, Ehrengruber MU, Renggli M, Hinkkanen AE. Vähä-Koskela MJ, et al. J Neurovirol. 2003 Feb;9(1):1-15. doi: 10.1080/13550280390173382. J Neurovirol. 2003. PMID: 12587064

6

Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.

Vähä-Koskela MJ, Kallio JP, Jansson LC, Heikkilä JE, Zakhartchenko VA, Kallajoki MA, Kähäri VM, Hinkkanen AE. Vähä-Koskela MJ, et al. Cancer Res. 2006 Jul 15;66(14):7185-94. doi: 10.1158/0008-5472.CAN-05-2214. Cancer Res. 2006. PMID: 16849565

7

Oncolytic viruses in cancer therapy.

Vähä-Koskela MJ, Heikkilä JE, Hinkkanen AE. Vähä-Koskela MJ, et al. Cancer Lett. 2007 Sep 8;254(2):178-216. doi: 10.1016/j.canlet.2007.02.002. Epub 2007 Mar 23. Cancer Lett. 2007. PMID: 17383089 Free PMC article. Review.

8

Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles.

Autio KP, Ruotsalainen JJ, Anttila MO, Niittykoski M, Waris M, Hemminki A, Vähä-Koskela MJ, Hinkkanen AE. Autio KP, et al. BMC Vet Res. 2015 Jul 28;11:170. doi: 10.1186/s12917-015-0498-2. BMC Vet Res. 2015. PMID: 26215394 Free PMC article.

9

Interferon-β sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models.

Ruotsalainen J, Martikainen M, Niittykoski M, Huhtala T, Aaltonen T, Heikkilä J, Bell J, Vähä-Koskela M, Hinkkanen A. Ruotsalainen J, et al. Mol Ther. 2012 Aug;20(8):1529-39. doi: 10.1038/mt.2012.53. Epub 2012 Mar 20. Mol Ther. 2012. PMID: 22434140 Free PMC article.

10

Semliki Forest virus vectors expressing transforming growth factor beta inhibit experimental autoimmune encephalomyelitis in Balb/c mice.

Vähä-Koskela MJ, Kuusinen TI, Holmlund-Hampf JC, Furu PT, Heikkilä JE, Hinkkanen AE. Vähä-Koskela MJ, et al. Biochem Biophys Res Commun. 2007 Apr 13;355(3):776-81. doi: 10.1016/j.bbrc.2007.02.026. Epub 2007 Feb 14. Biochem Biophys Res Commun. 2007. PMID: 17316567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page